©The Author(s) 2016.
World J Hepatol. Dec 8, 2016; 8(34): 1502-1510
Published online Dec 8, 2016. doi: 10.4254/wjh.v8.i34.1502
Published online Dec 8, 2016. doi: 10.4254/wjh.v8.i34.1502
Table 1 Clinical data of patients with bilobar colorectal liver metastases in this study
| Demographic, clinical and pathological factors | Total (n) |
| All patients (n = 136) | |
| All surgery patients (n = 71) | |
| Demographic factors | |
| Age > 65 yr | 68 |
| Male gender | 99 |
| Synchronous presentation | 80 |
| Down-staging therapy | 70 |
| Oxaliplatin-based regimen | 60 |
| Irinotecan-based regimen | 10 |
| Addition of biological agent | 30 |
| Surgical factors (n = 71) | |
| Hemi-hepatectomy or more | 22 |
| Histo-pathological factor (n = 71) | |
| Largest tumour size ≥ 5 cm | 11 |
| Number of metastases < 4 | 44 |
| Lymphatic invasion present | 15 |
| Vascular invasion present | 28 |
| Peri-neural invasion present | 9 |
| Biliary invasion present | 25 |
| Resection margin (R0) | 40 |
- Citation: Di Carlo S, Yeung D, Mills J, Zaitoun A, Cameron I, Gomez D. Resection margin influences the outcome of patients with bilobar colorectal liver metastases. World J Hepatol 2016; 8(34): 1502-1510
- URL: https://www.wjgnet.com/1948-5182/full/v8/i34/1502.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i34.1502